Hôpital Nord Franche-Comté
Trévenans, 90400, France
NCT Number: NCT06490497
Cancers of the central nervous system have a poor prognosis. Glioblastoma is most common glial tumor of the central nervous system. The presence of a tumour in the brain determines the particular and specific nature of care for these patients and their families. Symptoms affect daily life and the balance of the family sphere.It's easy to imagine a difficult and disturbed family's daily routine.
Caregivers find themselves in great distress but can still benefit from support to lighten the domestic burden, and financial burden, thanks to the various recommendations of successive Cancer Plans. In fact, support for patients and their families during the illness and after is one of the key points of the programs in place. The aim of this research will be to provide food for thought in order to improve the support provided to family and friends.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Trévenans, 90400, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
individual interviews semi-directive
Time frame: Day 1
Identify the difficulties and specific needs of a caregiver in the particular context of a person with glioblastoma.
Hopital Nord Franche-Comte
Other
Analysis of the Expectations and Needs of a Caregiver of a Glioblastoma Patient Undergoing in Oncology
Acronym: GLOIOS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01339052
Astrocytoma, Brain Diseases
Los Angeles, California, United States
View Trial DetailsNCT02902757
Astrocytoma, Glioblastoma
Los Angeles, California, United States
View Trial DetailsNCT05635734
Astrocytoma, Glioblastoma
Barcelona, Spain
View Trial DetailsNCT03477513
Astrocytoma, Glioblastoma
Philadelphia, Pennsylvania, United States
View Trial Details